Ulcers from diabetes? New shoe insole could provide healing on-the-go
(Purdue University) Purdue University researchers have developed a shoe insole that could help make the healing process more portable for the 15 percent of Americans who develop ulcers as a result of diabetes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 15, 2018 Category: International Medicine & Public Health Source Type: news
Health Tip: What Triggers Peptic Ulcers?
-- The most common symptom of a peptic ulcer is a dull or burning pain in your stomach, the National Institute of Diabetes and Digestive and Kidney Diseases says.
Pain typically is felt between your belly button and breast bone, most often when... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 13, 2018 Category: General Medicine Source Type: news
Diabetic foot ulcers heal quickly with nitric oxide technology
(Michigan Technological University) Around the world, 425 million people live with diabetes and upwards of 15 percent develop foot ulcers, which increases their risk of death 2.5 times. A new nitric oxide-releasing technology has the potential to cut down the healing time of diabetic foot ulcers from 120 days to 21 days. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2018 Category: International Medicine & Public Health Source Type: news
Be'Smart' With New Technology for Diabetic Foot Monitoring Be'Smart' With New Technology for Diabetic Foot Monitoring
Dr Neil Reeves urges clinicians to embrace new technologies such as pressure-sensing insoles to help patients take control of monitoring their health and prevent diabetic foot ulceration. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 11, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Commentary Source Type: news
Report: MiMedx held lower-cost grafts from federal hospitals
MiMedx (NSDQ:MDXG), already embroiled in an internal accounting snafu and several federal probes, reportedly held from government hospitals some of the lower-cost products it made available to private hospitals.
In limiting its regenerative wound care offering to U.S. Veteran Affairs Dept. and other federal caregivers, Marietta, Ga.-based MiMedx ran up the tab on taxpayers, the Wall Street Journal reported.
In September, MiMedx said a probe into its accounting practices turned up “conduct detrimental to the business or reputation of the company” on the part of four departed executives, following the July ouster of...
Source: Mass Device - October 5, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Legal News Regenerative Medicine Wound Care defensedepartment MiMedx Group Inc. U.S. Veterans Affairs Dept. (VA) Source Type: news
' Smart' Insoles Reduce Diabetic Foot Ulcer Recurrence'Smart' Insoles Reduce Diabetic Foot Ulcer Recurrence
Pressure-sensing smart insoles that provide a wearer with feedback on high pressure points on their feet reduced diabetic foot ulcer recurrence in high-risk patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 2, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
LeucoPatch Promising in Hard-to-Heal Diabetic Foot Ulcers LeucoPatch Promising in Hard-to-Heal Diabetic Foot Ulcers
Patches made of autologous leucocytes, platelets, and fibrin (LeucoPatch) improve and hasten healing in hard-to-heal diabetic foot ulcers compared with good standard of care, show new trial data.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 28, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
EO2 Announces Positive Results from Two Recent Studies: Double-Blind Randomized Study Evaluates Continuous Diffusion of Oxygen in Patients with Chronic Wounds and Second Pilot Study Builds on Growing Body of Clinical Evidence for the EO2 O2 Delivery System
SAN ANTONIO, Sept. 28, 2018 -- (Healthcare Sales & Marketing Network) -- EO2 Concepts announced today the publication of a randomized, double-blind, multi-center study to evaluate the company's innovative, wearable EO2 Oxygen Delivery System (EO2 System) ... Devices, Wound Care EO2 Concepts, EO2 System, CDO therapy, diabetic foot ulcer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 28, 2018 Category: Pharmaceuticals Source Type: news
A Blood Clot Product for Neuropathic Diabetic Foot Ulcers A Blood Clot Product for Neuropathic Diabetic Foot Ulcers
How did the application of a blood clot product to chronic neuropathic diabetic foot ulcers perform in terms of adverse events and wound healing?Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 12, 2018 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news
7 medtech stories we missed this week: August 3, 2018
[Image from unsplash.com]From Esaote launching its new ultrasound device to Nipro’s Infraredx launching in Japan, here are seven medtech stories we missed this week but thought were still worth mentioning.
1. Esaote launches new ultrasound devices
Esaote announced in an Aug. 2 press release that it has launched its new MyLab X7, MyLab X6 and MyLab X5 ultrasound systems. The MyLab X7 offers faster and more reliable ultrasounds with intuitive usability and ergonomics. MyLab X5 has zero-click automatic that speeds up assessments and enhances image quality.
2. Bonesupport inks deal with MTF Biologics
Bonesupport and MT...
Source: Mass Device - August 3, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Catheters Diagnostics Food & Drug Administration (FDA) Hospital Care Imaging Regulatory/Compliance Software / IT Ultrasound Bonesupport Esaote InfraReDx Inc. ivwatch MedTech Mindshare Medical Modulated Imaging MTF Bi Source Type: news
Driving Medical IoT Concepts with Force-Sensitive Resistor Technology
The Internet of Things (IoT) represents a growing wave of change that brings several new challenges to design engineers across all industries and markets. While it is a somewhat nebulous concept, IoT is broadly defined as a network of smart devices that communicate with one another wirelessly, with little-to-no direct human interaction.
In general, physicians and patients are becoming more accepting of medical treatment methods that offer the best opportunity for patients to live a normal life. Human contact will always be an important part in all medical treatment, but the development of smart medical devices, systems, an...
Source: MDDI - July 18, 2018 Category: Medical Devices Authors: Rob Podoloff and Andy Dambeck Tags: Digital Health Source Type: news
7 medtech stories we missed this week: July 13, 2018
[Image from unsplash.com]From Angiodroid receiving CE Mark approval to Masimo launching its vital signs app, here are seven medtech stories we missed this week but thought were still worth mentioning.
1. Angiodroid wins CE Mark for Angiopulse IABP
Angiodroid announced in a July 11 press release that it has received CE Mark approval for its AngioPulse intra-aortic balloon pump device. The AngioPulse uses a new system for intra-aortic balloon pumps based on pressure regulation. It is designed for weaning solutions and is suitable for all types of patients needing intra-aortic balloon pump therapy.
2. Visura Technologies wi...
Source: Mass Device - July 13, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Diagnostics Food & Drug Administration (FDA) Imaging Patient Monitoring Regulatory/Compliance Surgical Ultrasound angiodroid Healcerio Lipogems Masimo MedTech Oculocare ReDress Visura Technologies Source Type: news
Sanuwave Health, HyperMed partner for DermaPace diabetic foot ulcer study
Sanuwave Health (OTC:SNWV) said yesterday it is partnering with HyperMed to sponsor a clinical investigation exploring Sanuwave’s DermaPace system designed for treating diabetic foot ulcers.
The joint study will look to quantify the level of increased perfusion and oxygenation during and after treatment with the DermaPace, Suwanee, Ga.-based Sanuwave said. The study will use HyperMed’s Hyperview spectral imaging device to measure oxygen saturation, oxyhemoglobin levels and deoxyhemoglobin levesl in superficial tissue.
Sanuwave said that an initial case series in the study will be performed at two sites, Newark...
Source: Mass Device - July 12, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Clinical Trials Regenerative Medicine Wound Care SANUWAVE Health Inc. Source Type: news
Turning Surgeons Into Innovators Without Taking Them Out of the OR
Academic hospitals have all the makings for rich medical device development. They have physicians to identify surgical needs, researchers to test theories, bioengineers to design and create devices and patients to participate in clinical trials.
However, disconnect between engineering and surgical departments makes innovation a challenge. So does surgeons' all-consuming job Number One—treating patients.
Surgical Innovations, part of the University of California, San Francisco's Department of Surgery and Bioengineering & Therapeutic Sciences, aims to open communication between clinical academic surgeons and bioenginee...
Source: MDDI - June 6, 2018 Category: Medical Devices Authors: Heather R. Johnson Tags: R & D Source Type: news
New plaster uses nitric oxide gas to heal wounds faster
Professor Steve Bain, from the Diabetes Research Unit at Swansea University, said the gas plaster had the potential to radically improve healing in many patients with foot ulcers. (Source: the Mail online | Health)
Source: the Mail online | Health - April 27, 2018 Category: Consumer Health News Source Type: news
